Search

Your search keyword '"AMYOTROPHIC lateral sclerosis"' showing total 91,696 results

Search Constraints

Start Over You searched for: Descriptor "AMYOTROPHIC lateral sclerosis" Remove constraint Descriptor: "AMYOTROPHIC lateral sclerosis"
91,696 results on '"AMYOTROPHIC lateral sclerosis"'

Search Results

208. NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration.

209. Disruption of nuclear speckle integrity dysregulates RNA splicing in C9ORF72-FTD/ALS.

210. CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis.

211. Elevated peripheral inflammation is associated with choroid plexus enlargement in independent sporadic amyotrophic lateral sclerosis cohorts.

212. Microvascular abnormalities in skin capillaries of individuals with amyotrophic lateral sclerosis.

213. Slowly progressing Amyotrophic lateral sclerosis associated with the F21L variant in the SOD1 gene: Demographic and clinical characteristics.

214. NIV@Home: a pilot randomized controlled trial of in-home noninvasive ventilation initiation compared to a single-day admission model.

215. ALS-like pathology diminishes swelling of spinal astrocytes in the SOD1 animal model.

216. A review of proposed mechanisms for neurodegenerative disease.

217. Preservation of masseter muscle until the end stage in the SOD1G93A mouse model for ALS.

218. Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study.

219. A qualitative exploratory study into medical, nursing and allied health professional experiences of elective withdrawal of non‐invasive ventilation in a motor neurone disease cohort.

220. Cathepsins and neurological diseases: a Mendelian randomization study.

221. Nerve ultrasound in amyotrophic lateral sclerosis: systematic review and meta-analysis.

222. A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach.

223. Spanish adaptation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)

224. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.

225. Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy.

226. Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model.

227. Bibliometric analysis of microRNAs and Parkinson's disease from 2014 to 2023.

228. Speech motor impairment in ALS is associated with multiregional cortical thinning beyond primary motor cortex.

229. Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis.

230. Small organism models for mode of action research on anti-ageing and nootropic herbs, foods, and formulations.

231. ALSUntangled #76: Wahls protocol.

232. Somatosensory temporal discrimination analysis reveals impaired processing in amyotrophic lateral sclerosis.

233. Priorities and Recommendations to Make ALS a Livable Disease Emanating from the 2024 National Academies of Sciences, Engineering, and Medicine Report Living with ALS.

234. Automated pipeline for denoising, missing data processing, and feature extraction for signals acquired via wearable devices in multiple sclerosis and amyotrophic lateral sclerosis applications.

235. Secretion of endoplasmic reticulum protein VAPB/ALS8 requires topological inversion.

236. Graph theory network analysis reveals widespread white matter damage in brains of patients with classic ALS.

237. Clinical and imaging correlates of hyperorality in syndromes associated with frontotemporal lobar degeneration.

238. Creation of de novo cryptic splicing for ALS and FTD precision medicine.

239. Neuroprotective effects of ellorarxine in neuronal models of degeneration.

240. Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1G93A mice.

241. Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies.

242. Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome.

243. End-of-Life and Hospice Care in Neurologic Diseases.

244. Clinical and Sociodemographic Factors Related to Amyotrophic Lateral Sclerosis in Spain: A Pilot Study.

245. Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model.

246. Mitochondrial genome variants associated with amyotrophic lateral sclerosis and their haplogroup distribution.

247. Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.

248. Acute stress differently modulates interneurons excitability and synaptic plasticity in the primary motor cortex of wild‐type and SOD1G93A mouse model of ALS.

249. Effect of Sclerosis Bands in Femoral Head Necrosis on Non‐Vascularized Fibular Grafting—A Finite Element Study.

250. Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.

Catalog

Books, media, physical & digital resources